Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center
- PMID: 15337617
- DOI: 10.1016/j.jns.2004.05.009
Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center
Abstract
Background: Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri (PTC), is a condition characterized by increased intracranial pressure without clinical, laboratory or radiologic evidence of an intracranial space-occupying lesion, meningeal inflammation or venous outflow obstruction. Previous population-based studies evaluated the presenting clinical features of IIH in North-Eastern Libya, Iowa, Louisiana, Minnesota, Northern Ireland, Israel and Western Turkey. However, we report the demographic patterns of a metropolitan North American city.
Methods: We performed a retrospective study of all patients with an initial IIH diagnosis and follow-up at the Detroit Medical Center (DMC), Michigan from 1985 to 2002. Medical records of 174 patients were reviewed, with 77 patients fitting the diagnostic criteria.
Results: Seventy-seven patients, 71 females (92.2%) and 6 males (7.8%) were identified. Age ranged from 10 to 50 years, with a mean of 34 years. Fifty patients (65%) were African-American and 24 patients (31%) were Caucasian. The most common presentation was isolated headache (28.6%). Nineteen patients (24.7%) were asymptomatic. Obesity was described in 65 of 74 patients (87.8%) evaluated for body dimensions.
Conclusions: We report an increased number of asymptomatic patients after routine ophthalmic examination. Obese females in metropolitan Detroit would benefit from routine eye evaluations to avoid potential visual loss related to papilledema.
Similar articles
-
Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995).Ulster Med J. 2001 May;70(1):31-5. Ulster Med J. 2001. PMID: 11428322 Free PMC article.
-
The relationship between idiopathic intracranial hypertension and obesity.Headache. 2009 Feb;49(2):178-84. doi: 10.1111/j.1526-4610.2008.01240.x. Headache. 2009. PMID: 19222591
-
Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.Neurology. 2008 Feb 19;70(8):634-40. doi: 10.1212/01.wnl.0000299893.43918.a8. Neurology. 2008. PMID: 18285538
-
What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment.Cephalalgia. 2006 Apr;26(4):384-99. doi: 10.1111/j.1468-2982.2005.01055.x. Cephalalgia. 2006. PMID: 16556239 Review.
-
[Treatment and prognosis of idiopathic intracranial hypertension in children. Retrospective study (1995-2009) and literature review].Arch Pediatr. 2011 Nov;18(11):1139-47. doi: 10.1016/j.arcped.2011.08.017. Epub 2011 Oct 12. Arch Pediatr. 2011. PMID: 21992894 Review. French.
Cited by
-
Socioeconomic and Geographic Disparities in Idiopathic Intracranial Hypertension.Neurology. 2021 Jun 8;96(23):e2854-e2860. doi: 10.1212/WNL.0000000000012037. Epub 2021 May 12. Neurology. 2021. PMID: 33980705 Free PMC article.
-
Management of headache in the elderly.Drugs Aging. 2010 May;27(5):377-98. doi: 10.2165/11315980-000000000-00000. Drugs Aging. 2010. PMID: 20450236 Review.
-
Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.Neurol Sci. 2023 Jun;44(6):2131-2135. doi: 10.1007/s10072-023-06616-z. Epub 2023 Jan 23. Neurol Sci. 2023. PMID: 36689008 Free PMC article.
-
Risk factors for idiopathic intracranial hypertension in men: a case-control study.J Neurol Sci. 2010 Mar 15;290(1-2):86-9. doi: 10.1016/j.jns.2009.11.001. Epub 2009 Nov 30. J Neurol Sci. 2010. PMID: 19945715 Free PMC article.
-
Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent.Biomolecules. 2020 Sep 16;10(9):1324. doi: 10.3390/biom10091324. Biomolecules. 2020. PMID: 32947869 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources